Factor V–Leiden/Cambridge (Crucell)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFactor V–Leiden/Cambridge (Crucell)

Drug Alias NameFactor VL/C

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionProthrombin stimulants

TargetsProthrombin

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCrucell NV

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCrucell NV

Active IndicationsN/A

Inactive IndicationsHemophilia A

ATC CodeN/A